151 related articles for article (PubMed ID: 27487259)
1. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder.
Woo YS; Bahk WM; Park YM; Chung S; Yoon BH; Won S; Lee JG; Lee HB; Kim W; Jeong JH; Lee K; Kim MD
Int Clin Psychopharmacol; 2016 Sep; 31(5):275-86. PubMed ID: 27487259
[TBL] [Abstract][Full Text] [Related]
2. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
[TBL] [Abstract][Full Text] [Related]
3. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
[TBL] [Abstract][Full Text] [Related]
4. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
[TBL] [Abstract][Full Text] [Related]
5. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.
Kemp DE; Calabrese JR; Eudicone JM; Ganocy S; Tran QV; McQuade RD; Marcus RN; Vester-Blokland E; Owen R; Carlson BX
Psychopharmacol Bull; 2010; 43(2):5-27. PubMed ID: 21052040
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
Thase ME; Bowden CL; Nashat M; Eudicone JM; Marcus R; McQuade RD; Carlson BX
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):121-31. PubMed ID: 22296512
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Sachs G; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Impellizzeri C; Kaplita S; Rollin L; Iwamoto T;
J Psychopharmacol; 2006 Jul; 20(4):536-46. PubMed ID: 16401666
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms.
Schweitzer I; Sarris J; Tuckwell V; Maguire K; Smith D; Ng C
Int J Bipolar Disord; 2013; 1():4. PubMed ID: 25505671
[TBL] [Abstract][Full Text] [Related]
12. Treatment of bipolar mania with atypical antipsychotics.
Chengappa KN; Suppes T; Berk M
Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
14. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.
Han C; Wang SM; Kwak KP; Won WY; Lee H; Chang CM; Tang TC; Pae CU
J Psychiatr Res; 2015; 66-67():84-94. PubMed ID: 26013203
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G;
Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341
[TBL] [Abstract][Full Text] [Related]
18. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
20. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
